Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii

Journal of Clinical Microbiology

Volumn 38, Issue 11, 2000, Pages 4086-4095

  Corbella, X ^a   Montero, A ^a   Pujol, M ^a   Dominguez M A ^a   Ayats, J ^a   Argerich, M J ^a   Garrigosa, F ^a   Ariza, J ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM; PALINDROMIC DNA;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; GEL ELECTROPHORESIS; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SPAIN;

ACINETOBACTER BAUMANNII; ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); UNCULTURED ACTINOMYCETE;

EID: 0034460147     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.11.4086-4095.2000     Document Type: Article

References (80)

1. Statement of the Antibiogram Committee of the French Society for Microbiology
2. Consequences of increasing resistance to antimicrobial agents
3. Worldwide emergence of carbapenem-resistant Acinetobacter spp.
4. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
5. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients
6. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units
7. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features
8. Hospital infection with Acinetobacter spp.: An increasing problem
9. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases
10. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI 2
11. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: Correlation with amikacin usage
12. A reassessment of the in-vitro activity of colistin sulphomethate sodium
13. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection ventilatory equipment
14. Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings, and pronostic features
15. Imipenem resistance among Acinetobacter baumannii: Association with reduced expression of a 33-36 kDa outer membrane protein
16. Epidemiology of drug resistance: Implications for a post-antimicrobial era
17. Investigation of an outbreak of Acinetobacter calcoaceticus var. anitratus infections in an adult intensive care unit
18. Relevance of digestive tract colonization in the epidemiology of multiresistant Acinetobacter baumannii
19. Efficacy of sulbactam alone and in association with ampicillin in nosocomial infections due to Acinetobacter baumannii
20. Environmental sampling of Acinetobacter baumannii: Moistened swabs versus moistened sterile gauze pads
21. Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital
22. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates
23. Correlation of typing methods for Acinetobacter isolates from hospital outbreaks
24. Acinetobacter - Microbiology
25. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species; assessment by quantitative culture of samples obtained by a protected specimen brush
26. A hospital outbreak of antibiotic resistant Acinetobacter anitratus: Epidemiology and control
27. PCR-amplified 16S and 23S rDNA restriction analysis for the identification of Acinetobacter strains at the DNA group level
28. CDC definitions for nosocomial infections
29. Endemic occurrence of Acinetobacter calcoaceticus biovar anitratus in an intensive care unit
30. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: Evidence for long survival of Acinetobacter calcoaceticus
31. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
32. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
33. New mechanisms of bacterial resistance to antimicrobial agents
34. Treatment of multi-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam
35. Bactericidal in-vitro activity of β-lactams and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: Effect of combination with aminoglycosides
36. Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibilty testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical response
37. Polymyxins
38. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp. Antimicrob
39. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
40. A simplified acute physiology score for ICU patients
41. Nosocomial acquisition of multiresistant A. baumannii: Risk factors and prognosis
42. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: Emergence of resistance to imipenem
43. Application of pulsed-field electrophoresis to molecular epidemiology
44. Gram negative bacteremia
45. Linking antimicrobial use to nosocomial infections: The role of a combined laboratory-epidemiology approach
46. Emergence of enterococcus as a significant pathogen
47. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii
48. The life and times of the Enterococcus
49. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica
50. The crisis in antibiotic resistance
51. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
52. Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital
53. Clinical problems posed by multiresistant nonfermenting Gram-negative pathogens
54. Acinetobacter calcoaceticus: A nosocomial pathogen with an unusual seasonal pattern
55. Acinetobacter calcoaceticus biovar. anitratus septicaemia in a neonatal intensive care unit: Epidemiology and control
56. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: A randomized, double-blind, placebo-controlled, multicenter trial
57. Transferable imipenem-resistance in Acinetobacter species from a clinical source
58. Plasmid DNA profiles of Acinetobacter baumannii: Clinical application in a complex endemic setting
59. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates
60. Nosocomial bacteremia due to Acinetobacter baumannii: Clinical features, epidemiology, and predictors of mortality
61. An outbreak of infection in burn patients: Contamination of patients' mattresses
62. Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients
63. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France
64. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic methods
65. The digestive tract is a major site for Acinetobacter baumannii colonization in intensive care unit patients
66. Multiple-antibiotic-resistant pathogenic bacteria
67. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus
68. Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains
69. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex
70. Cloning and nucleotide sequence analysis of a gene enconding a OXA-derived β-lactamase in A. baumannii
71. Spread of amikacin resistance in A. baumannii strains isolated in Spain due to an epidemic strain
72. Successful treatment of carbapenem-resistant Acinetobacter baumannii ventriculitis with intraventricular colistin sulphomethate sodium
73. Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology
74. Pillows, an unexpected source of Acinetobacter
75. Survival of Acinetobacter baumannii on dry surfaces
76. Vancomycin-resistant Staphylococcus aureus: Infection control considerations
77. In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model
78. Infections caused by imipenem-resistant A. calcoaceticus biotype anitratus